HCPCS Codes for Medical care


  • G9763

    Patient did not have at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays
  • G9764

    Patient has been treated with a systemic medication for psoriasis vulgaris
  • G9765

    Documentation that the patient declined change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic medication for at least six consecutive months (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi
  • G9766

    Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment
  • G9767

    Hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment
  • G9768

    Patients who utilize hospice services any time during the measurement period
  • G9769

    Patient had a bone mineral density test in the past two years or received osteoporosis medication or therapy in the past 12 months
  • G9770

    Peripheral nerve block (pnb)
  • G9771

    At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time
  • G9772

    Documentation of medical reason(s) for not achieving at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time (e.g., emergency cases, intentional hypothermia, etc.)
  • G9773

    At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) not achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time, reason not given
  • G9774

    Patients who have had a hysterectomy
  • G9775

    Patient received at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively
  • G9776

    Documentation of medical reason for not receiving at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason)
  • G9777

    Patient did not receive at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively
  • G9778

    Patients who have a diagnosis of pregnancy at any time during the measurement period
  • G9779

    Patients who are breastfeeding at any time during the performance period
  • G9780

    Patients who have a diagnosis of rhabdomyolysis at any time during the performance period
  • G9781

    Documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease [esrd], or other medical reasons)
  • G9782

    History of or active diagnosis of familial hypercholesterolemia
  • G9783

    Documentation of patients with diabetes who have a most recent fasting or direct ldl- c laboratory test result < 70 mg/dl and are not taking statin therapy
  • G9784

    Pathologists/dermatopathologists providing a second opinion on a biopsy
  • G9785

    Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist
  • G9786

    Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) was not sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist
  • G9787

    Patient alive as of the last day of the measurement year
  • G9788

    Most recent bp is less than or equal to 130/80 mm hg
  • G9789

    Blood pressure recorded during inpatient stays, emergency room visits, or urgent care visits
  • G9790

    Most recent bp is greater than 130/80 mm hg, or blood pressure not documented
  • G9791

    Most recent tobacco status is tobacco free
  • G9792

    Most recent tobacco status is not tobacco free
  • G9793

    Patient is currently on a daily aspirin or other antiplatelet
  • G9794

    Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g., history of gastrointestinal bleed, intra-cranial bleed, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period)
  • G9795

    Patient is not currently on a daily aspirin or other antiplatelet
  • G9796

    Patient is currently on a high intensity statin therapy
  • G9797

    Patient is not on a high intensity statin therapy
  • G9798

    Discharge(s) for ami between july 1 of the year prior measurement period to june 30 of the measurement period
  • G9799

    Patients with a medication dispensing event indicator of a history of asthma any time during the patient's history through the end of the measure period
  • G9800

    Patients who are identified as having an intolerance or allergy to beta-blocker therapy
  • G9801

    Hospitalizations in which the patient was transferred directly to a non-acute care facility for any diagnosis
  • G9802

    Patients who use hospice services any time during the measurement period
  • G9803

    Patient prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami
  • G9804

    Patient was not prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami
  • G9805

    Patients who use hospice services any time during the measurement period
  • G9806

    Patients who received cervical cytology or an hpv test
  • G9807

    Patients who did not receive cervical cytology or an hpv test
  • G9808

    Any patients who had no asthma controller medications dispensed during the measurement year
  • G9809

    Patients who use hospice services any time during the measurement period
  • G9810

    Patient achieved a pdc of at least 75% for their asthma controller medication
  • G9811

    Patient did not achieve a pdc of at least 75% for their asthma controller medication
  • G9812

    Patient died including all deaths occurring during the hospitalization in which the operation was performed, even if after 30 days, and those deaths occurring after discharge from the hospital, but within 30 days of the procedure